238 related articles for article (PubMed ID: 17369830)
1. SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion.
Kitamura T; Kometani K; Hashida H; Matsunaga A; Miyoshi H; Hosogi H; Aoki M; Oshima M; Hattori M; Takabayashi A; Minato N; Taketo MM
Nat Genet; 2007 Apr; 39(4):467-75. PubMed ID: 17369830
[TBL] [Abstract][Full Text] [Related]
2. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
3. Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis.
Inamoto S; Itatani Y; Yamamoto T; Minamiguchi S; Hirai H; Iwamoto M; Hasegawa S; Taketo MM; Sakai Y; Kawada K
Clin Cancer Res; 2016 Jan; 22(2):492-501. PubMed ID: 26341919
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model.
Kitamura T; Fujishita T; Loetscher P; Revesz L; Hashida H; Kizaka-Kondoh S; Aoki M; Taketo MM
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13063-8. PubMed ID: 20616008
[TBL] [Abstract][Full Text] [Related]
5. Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.
Yamamoto T; Kawada K; Itatani Y; Inamoto S; Okamura R; Iwamoto M; Miyamoto E; Chen-Yoshikawa TF; Hirai H; Hasegawa S; Date H; Taketo MM; Sakai Y
Clin Cancer Res; 2017 Feb; 23(3):833-844. PubMed ID: 27492974
[TBL] [Abstract][Full Text] [Related]
6. Keeping out the bad guys: gateway to cellular target therapy.
Kitamura T; Taketo MM
Cancer Res; 2007 Nov; 67(21):10099-102. PubMed ID: 17974948
[TBL] [Abstract][Full Text] [Related]
7. CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis.
Hirai H; Fujishita T; Kurimoto K; Miyachi H; Kitano S; Inamoto S; Itatani Y; Saitou M; Maekawa T; Taketo MM
Clin Exp Metastasis; 2014 Dec; 31(8):977-89. PubMed ID: 25326065
[TBL] [Abstract][Full Text] [Related]
8. CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model.
Li B; Zhang S; Huang N; Chen H; Wang P; Yang J; Li Z
Oncol Rep; 2019 Jan; 41(1):608-618. PubMed ID: 30365155
[TBL] [Abstract][Full Text] [Related]
9. CCL15/CCR1 axis is involved in hepatocellular carcinoma cells migration and invasion.
Li Y; Wu J; Zhang P
Tumour Biol; 2016 Apr; 37(4):4501-7. PubMed ID: 26501423
[TBL] [Abstract][Full Text] [Related]
10. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases.
Swamydas M; Ricci K; Rego SL; Dréau D
Cell Adh Migr; 2013; 7(3):315-24. PubMed ID: 23722213
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion.
Wu X; Fan J; Wang X; Zhou J; Qiu S; Yu Y; Liu Y; Tang Z
Biochem Biophys Res Commun; 2007 Apr; 355(4):866-71. PubMed ID: 17336272
[TBL] [Abstract][Full Text] [Related]
13. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression.
Yang X; Lu P; Fujii C; Nakamoto Y; Gao JL; Kaneko S; Murphy PM; Mukaida N
Int J Cancer; 2006 Apr; 118(8):1869-76. PubMed ID: 16284949
[TBL] [Abstract][Full Text] [Related]
14. Disruption of CCR1-mediated myeloid cell accumulation suppresses colorectal cancer progression in mice.
Kiyasu Y; Kawada K; Hirai H; Ogawa R; Hanada K; Masui H; Nishikawa G; Yamamoto T; Mizuno R; Itatani Y; Kai M; Taketo MM; Sakai Y
Cancer Lett; 2020 Sep; 487():53-62. PubMed ID: 32473241
[TBL] [Abstract][Full Text] [Related]
15. The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system.
Wiercinska E; Naber HP; Pardali E; van der Pluijm G; van Dam H; ten Dijke P
Breast Cancer Res Treat; 2011 Aug; 128(3):657-66. PubMed ID: 20821046
[TBL] [Abstract][Full Text] [Related]
16. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
17. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts.
Lean JM; Murphy C; Fuller K; Chambers TJ
J Cell Biochem; 2002; 87(4):386-93. PubMed ID: 12397598
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas.
Kitamura T; Biyajima K; Aoki M; Oshima M; Taketo MM
Lab Invest; 2009 Jan; 89(1):98-105. PubMed ID: 19002110
[TBL] [Abstract][Full Text] [Related]
19. Smad4 haploinsufficiency in mouse models for intestinal cancer.
Alberici P; Jagmohan-Changur S; De Pater E; Van Der Valk M; Smits R; Hohenstein P; Fodde R
Oncogene; 2006 Mar; 25(13):1841-51. PubMed ID: 16288217
[TBL] [Abstract][Full Text] [Related]
20. TGFbeta1 selectively up-regulates CCR1 expression in primary murine astrocytes.
Han Y; Wang J; Zhou Z; Ransohoff RM
Glia; 2000 Mar; 30(1):1-10. PubMed ID: 10696139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
